Free Trial

SCYNEXIS (SCYX) Short Interest Ratio & Short Volume

SCYNEXIS logo
$1.01 +0.02 (+1.62%)
Closing price 03/27/2025 03:59 PM Eastern
Extended Trading
$1.02 +0.01 (+1.19%)
As of 03/27/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SCYNEXIS Short Interest Data

SCYNEXIS (SCYX) has a short interest of 695,200 shares, representing 1.89% of the float (the number of shares available for trading by the public). This marks a -8.03% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.3, indicating that it would take 3.3 days of the average trading volume of 189,287 shares to cover all short positions.

Current Short Interest
695,200 shares
Previous Short Interest
755,900 shares
Change Vs. Previous Month
-8.03%
Dollar Volume Sold Short
$647,926.40
Short Interest Ratio
3.3 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
38,981,000 shares
Short Percent of Float
1.89%
Today's Trading Volume
73,810 shares
Average Trading Volume
189,287 shares
Today's Volume Vs. Average
39%
Short Selling SCYNEXIS?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for SCYNEXIS and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SCYX Short Interest Over Time

SCYX Days to Cover Over Time

SCYX Percentage of Float Shorted Over Time

Remove Ads

SCYNEXIS Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/2025695,200 shares $647,926.40 -8.0%1.9%3.3 $0.93
2/28/2025755,900 shares $778,577.00 -10.2%2.1%3.4 $1.03
2/15/2025841,300 shares $942,256.00 +1.4%2.3%3.8 $1.12
1/31/2025830,100 shares $888,207.00 -1.8%N/A3.7 $1.07
1/15/2025845,000 shares $988,650.00 +3.9%N/A3.7 $1.17
12/31/2024813,700 shares $984,577.00 +19.9%N/A3.7 $1.21
12/15/2024678,500 shares $773,490.00 -14.7%N/A4.1 $1.14
11/30/2024795,400 shares $1.09 million -5.0%N/A5.5 $1.37
11/15/2024837,600 shares $1.01 million -3.4%N/A5.5 $1.20
10/31/2024867,000 shares $1.18 million -10.2%N/A5.9 $1.36
10/15/2024965,200 shares $1.46 million -4.4%N/A7 $1.51
9/30/20241,010,000 shares $1.50 million +2.5%N/A7.5 $1.49
9/15/2024985,800 shares $1.44 million -4.3%N/A7 $1.46
8/31/20241,030,000 shares $1.50 million -4.6%N/A7.2 $1.46
8/15/20241,080,000 shares $1.87 million +13.4%N/A7.2 $1.73
7/31/2024952,300 shares $2.03 million -13.4%N/A4.5 $2.13
7/15/20241,100,000 shares $2.40 million -5.2%N/A5 $2.18
6/30/20241,160,000 shares $2.32 million +12.6%N/A5.2 $2.00
6/15/20241,030,000 shares $2.10 million -6.4%N/A4.2 $2.04
5/31/20241,100,000 shares $2.66 million No ChangeN/A4.1 $2.42
5/15/20241,100,000 shares $2.49 million +12.7%N/A4.2 $2.26
4/30/2024976,500 shares $1.65 million -6.1%N/A4.8 $1.69
4/15/20241,040,000 shares $1.53 million +6.5%N/A5.3 $1.47
3/31/2024976,200 shares $1.44 million +3.3%N/A5.1 $1.47
3/15/2024945,500 shares $1.37 million -9.1%N/A4.5 $1.45
2/29/20241,040,000 shares $1.68 million -8.0%N/A5.3 $1.62
2/15/20241,130,000 shares $2.01 million -1.7%N/A5.4 $1.78
1/31/20241,150,000 shares $2.37 million -18.4%N/A5.2 $2.06
1/15/20241,410,000 shares $2.79 million No ChangeN/A5.8 $1.98
12/31/20231,410,000 shares $3.14 million +6.8%N/A5.4 $2.23
12/15/20231,320,000 shares $2.11 million -17.5%N/A4.8 $1.60
11/30/20231,600,000 shares $2.69 million +0.6%N/A4.8 $1.68
11/15/20231,590,000 shares $2.64 million +1.3%N/A4.4 $1.66
10/31/20231,570,000 shares $2.97 million -1.3%N/A3.6 $1.89
10/15/20231,590,000 shares $3.12 million +3.9%N/A3.7 $1.96
9/30/20231,530,000 shares $3.49 million +12.5%N/A3.8 $2.28
9/15/20231,360,000 shares $4.50 million +2.3%N/A3.5 $3.31
8/31/20231,330,000 shares $4.68 million +6.4%N/A3.9 $3.52
8/15/20231,250,000 shares $3.44 million -13.2%N/A3.7 $2.75
7/31/20231,440,000 shares $4.25 million -5.3%N/A4.8 $2.95
Ex CIA predicts 40% “double crash” – April 11 (Ad)

The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… They’re studying something far more alien… Something you’ve never seen before…

Click here for my latest prediction before it’s taken offline.
7/15/20231,520,000 shares $4.18 million -1.9%N/A4.1 $2.75
6/30/20231,550,000 shares $4.57 million -1.3%N/A3.3 $2.95
6/15/20231,570,000 shares $4.30 million -11.3%N/A1 $2.74
5/31/20231,770,000 shares $4.43 million +7.3%N/A0.9 $2.50
5/15/20231,650,000 shares $4.59 million -7.8%N/A0.9 $2.78
4/30/20231,790,000 shares $5.64 million -41.1%N/A1 $3.15
4/15/20233,040,000 shares $9.55 million +32.2%N/A1.8 $3.14
3/31/20232,300,000 shares $6.90 million +194.7%N/A1.4 $3.00
3/15/2023780,500 shares $999,040.00 +1.8%N/A2 $1.28
2/28/2023766,800 shares $1.14 million -2.1%N/A6.9 $1.49
2/15/2023783,000 shares $1.24 million -2.3%N/A7.1 $1.59
1/31/2023801,700 shares $1.47 million -8.8%N/A6.2 $1.84
1/15/2023879,200 shares $1.65 million -5.5%N/A6.4 $1.88
12/30/2022930,300 shares $1.45 million -2.7%N/A6.5 $1.56
12/15/2022956,100 shares $1.86 million -8.1%N/A7.1 $1.95
11/30/20221,040,000 shares $2.45 million -1.0%N/A8 $2.36
11/15/20221,050,000 shares $2.12 million -5.4%N/A9.6 $2.02
10/31/20221,110,000 shares $2.56 million +8.8%N/A10.8 $2.31
10/15/20221,020,000 shares $2.81 million -14.3%N/A9.5 $2.75
9/30/20221,190,000 shares $2.86 million +20.1%N/A10.3 $2.40
9/15/2022990,900 shares $2.84 million -23.2%N/A8.7 $2.87
8/31/20221,290,000 shares $3.26 million +1.6%N/A11.1 $2.53
8/15/20221,270,000 shares $3.72 million +17.6%N/A10.2 $2.93
7/31/20221,080,000 shares $2.49 million +2.9%N/A7.3 $2.31
7/15/20221,050,000 shares $2.16 million -8.7%N/A4.8 $2.06
6/30/20221,150,000 shares $2.14 million +10.6%N/A5.2 $1.86
6/15/20221,040,000 shares $1.97 million -10.3%N/A4.1 $1.89
5/31/20221,160,000 shares $2.45 million -25.2%N/A3.9 $2.11
5/15/20221,550,000 shares $3.21 million +24.0%N/A5.1 $2.07
4/30/20221,250,000 shares $3.34 million -9.4%N/A4 $2.67
4/15/20221,380,000 shares $4.62 million -5.5%N/A4.7 $3.35
3/31/20221,460,000 shares $5.71 million +5.0%N/A5.8 $3.91
3/15/20221,390,000 shares $5.62 million -9.2%N/A5.2 $4.04
2/28/20221,530,000 shares $6.40 million +7.0%N/A6.1 $4.18
2/15/20221,430,000 shares $6.56 million -11.7%N/A4.9 $4.59
1/31/20221,620,000 shares $7.94 million -46.5%N/A4.3 $4.90
1/15/20223,030,000 shares $18.33 million -1.9%N/A8.2 $6.05
12/31/20213,090,000 shares $18.85 million -14.4%N/A8.9 $6.10
12/15/20213,610,000 shares $25.63 million -1.1%N/A10.6 $7.10
11/30/20213,650,000 shares $26.94 million +12.7%N/A11.6 $7.38
11/15/20213,240,000 shares $21.87 million -3.0%N/A12 $6.75
10/29/20213,340,000 shares $16.73 million -4.8%N/A20.1 $5.01
10/15/20213,510,000 shares $19.55 million No ChangeN/A20.2 $5.57
9/30/20213,510,000 shares $18.60 million +2.3%N/A18.3 $5.30
9/15/20213,430,000 shares $20.24 million -1.4%N/A15.5 $5.90
8/31/20213,480,000 shares $22.69 million -3.1%N/A13.1 $6.52
8/13/20213,590,000 shares $22.47 million -2.5%N/A6 $6.26
7/30/20213,680,000 shares $25.65 million -1.3%18.0%6 $6.97
7/15/20213,730,000 shares $26.11 million -1.8%18.3%5.8 $7.00
6/30/20213,800,000 shares $27.97 million +4.7%19.1%5.8 $7.36
Ex CIA predicts 40% “double crash” – April 11 (Ad)

The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… They’re studying something far more alien… Something you’ve never seen before…

Click here for my latest prediction before it’s taken offline.
6/15/20213,630,000 shares $27.48 million +83.3%18.3%5.7 $7.57
5/28/20211,980,000 shares $18.97 million +81.7%10.0%3.2 $9.58
5/14/20211,090,000 shares $7.40 million -5.2%5.5%2.9 $6.79
4/30/20211,150,000 shares $8.45 million -10.9%5.8%2.7 $7.35
4/15/20211,290,000 shares $10.02 million -12.8%6.5%2.1 $7.77
3/31/20211,480,000 shares $11.44 million +21.3%7.5%2.3 $7.73
3/15/20211,220,000 shares $10.42 million +9.9%6.6%1.8 $8.54
2/26/20211,110,000 shares $8.75 million +40.6%6.0%1.7 $7.88
2/12/2021789,300 shares $6.87 million +21.3%7.5%1.3 $8.71
1/29/2021650,500 shares $4.76 million +97.2%6.2%1.3 $7.31
1/15/2021329,800 shares $2.62 million -46.5%3.1%0.8 $7.93
12/31/2020616,900 shares $4.49 million +72.6%6.0%2.7 $7.28
12/15/2020357,500 shares $2.74 million +52.6%3.5%2 $7.67
11/30/2020234,300 shares $1.58 million +15.2%2.3%2.3 $6.75
11/15/2020203,400 shares $1.17 million -3.4%2.0%2.6 $5.75
10/30/2020210,600 shares $920,322.00 +57.9%2.1%3 $4.37
10/15/2020133,400 shares $717,692.00 -4.5%1.3%1.8 $5.38
9/30/2020139,700 shares $616,077.00 -12.3%1.4%1.7 $4.41
9/15/2020159,200 shares $816,696.00 +14.3%1.6%2.1 $5.13
8/31/2020139,300 shares $787,045.00 -25.1%1.4%1.8 $5.65
8/14/2020186,000 shares $1.26 million -3.4%1.9%2 $6.77
7/31/2020192,600 shares $1.25 million -86.4%2.1%1.9 $6.48
7/15/20201,420,000 shares $9.80 million -13.4%15.4%13.5 $6.90
6/30/20201,640,000 shares $12.50 million -4.1%N/A1.5 $7.62
6/15/20201,710,000 shares $13.99 million -18.2%N/A1.6 $8.18
5/29/20202,090,000 shares $15.76 million -4.6%N/A1.9 $7.54
5/15/20202,190,000 shares $17.52 million +7.9%N/A2.2 $8.00
4/30/20202,030,000 shares $19.59 million +18.0%N/A2.1 $9.65
4/15/20201,720,000 shares $17.12 million +26.5%N/A1.9 $9.96
3/31/20201,360,000 shares $1.13 million -26.2%N/A1.4 $0.83

SCYX Short Interest - Frequently Asked Questions

What is SCYNEXIS's current short interest?

Short interest is the volume of SCYNEXIS shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 695,200 shares of SCYX short. 1.89% of SCYNEXIS's shares are currently sold short. Learn More on SCYNEXIS's current short interest.

What is a good short interest ratio for SCYNEXIS?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SCYX shares currently have a short interest ratio of 3.0. Learn More on SCYNEXIS's short interest ratio.

Which institutional investors are shorting SCYNEXIS?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of SCYNEXIS: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for SCYNEXIS?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.89% of SCYNEXIS's floating shares are currently sold short.

Is SCYNEXIS's short interest increasing or decreasing?

SCYNEXIS saw a decline in short interest during the month of March. As of March 15th, there was short interest totaling 695,200 shares, a decline of 8.0% from the previous total of 755,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does SCYNEXIS's short interest compare to its competitors?

1.89% of SCYNEXIS's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to SCYNEXIS: ADC Therapeutics SA (6.01%), Molecular Partners AG (0.11%), C4 Therapeutics, Inc. (12.66%), scPharmaceuticals Inc. (11.99%), Inventiva S.A. (0.97%), Greenwich LifeSciences, Inc. (11.14%), Larimar Therapeutics, Inc. (8.25%), Compugen Ltd. (2.30%), Zentalis Pharmaceuticals, Inc. (7.76%), Organigram Holdings Inc. (6.23%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short SCYNEXIS stock?

Short selling SCYX is an investing strategy that aims to generate trading profit from SCYNEXIS as its price is falling. SCYX shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against SCYNEXIS?

A short squeeze for SCYNEXIS occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SCYX, which in turn drives the price of the stock up even further.

How often is SCYNEXIS's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SCYX, twice per month. The most recent reporting period available is March, 15 2025.




This page (NASDAQ:SCYX) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners